Therapieoptionen bei immunvermittelten Enzephalomyelitiden [Therapeutic options for autoimmune encephalomyelitis]

Tools

Item Type:	Article
Title:	Therapieoptionen bei immunvermittelten Enzephalomyelitiden [Therapeutic options for autoimmune encephalomyelitis]
Creators Name:	Borisow, N., Prüss, H. and Paul, F.
Abstract:	Autoantibodies to neuronal tissue are becoming increasingly more important in the evaluation and classification of several neurological diseases, e.g. neuromyelitis optica, paraneoplastic syndromes of the central nervous system (CNS), stiff person syndrome or autoimmune epilepsy. As these disorders are rare, no evidence-based recommendations for therapy are available. Currently, immunomodulating or immunosuppressive drugs are administered in most cases. In paraneoplastic syndromes treatment of the underlying cancer is of considerable importance. This overview summarizes current experiences and recommendations in the treatment of autoimmune neurological disorders.
Keywords:	Autoantibodies, Autoimmune Diseases of the Nervous System, Encephalomyelitis, Immunologic Factors, Immunosuppressive Agents, Immunotherapy
Source:	Nervenarzt
ISSN:	0028-2804
Publisher:	Springer
Volume:	84
Number:	4
Page Range:	461-465
Date:	April 2013
Official Publication:	https://doi.org/10.1007/s00115-012-3608-4
PubMed:	View item in PubMed

Repository Staff Only: item control page